Breast Pathology Flashcards
What are risk factors for locoregional recurrence in DCIS
Four most important
-age <50
-size >2cm
-grade 3
-<2mm surgical margins (less considered a positive margin)
Additional
-comedo/solid subtype
-palpable/bloody discharge
-ER/PR negative
What are risk factors for invasive breast cancer recurrence
Patient
-age
-menopausal status
-race
Tumour
-size
-node status
-grade
-LVSI
-Genomic score
-receptor status
Treatment related
-surgical margin status (no ink on margin negative)
-systemic therapy
What are common symptoms of papilloma and what is the cause of these symptoms
Blood discharge: due to tortion of papilloma stalk
Serous discharge: due to intermittent blockage of duct
What is the median age of diagnosis by TCGA molecular subtypes
Luminal: older Medan age
Basal/ HER2: peak incidence in middle age. Almost half of breast cancers in younger women, 20% in older women
What are risk factors for the development of breast cancer
Female gender
Lifetime exposure to estrogen
Age
Genetic mutation inheritance
Environmental/lifestyle factors ( less relevance)
Reduced risk
-early pregnancy aged less than 20
-prolonged breast feeding
What proportion of breast cancers are thought to occur due to an inherited susceptibility
Quarter to one third
What percentage of breast cancers are associated with BRCA1 or BRCA2
3-6%
Which BRCA mutation is most commonly associated with ovarian cancer
BRCA1: 20-40% lifetime risk
BRCA2: 10-20%
What is the typical ER profile of BRCA associated breast cancers
BRCA1: Triple negative
BRCA2: more often ER positive
What pathway are the products of BRCA genes part of
Homologous recombination for repair of double stranded DNA breaks
What are the response rates to chemotherapy of difference TCGA subtypes of breast cancer
Luminal A: <10% (but good response to hormone therapy)
Luminal B: 10%
HER2: good response if ER negative
Basal: 30% response
What TCGA subtype of breast cancer is most commonly associated with Li Fraumeni syndrome
HER2+
In triple negative breast cancer without germline BRCA1 mutation, what is the most common change to the BRCA1 gene
Epigenetic silencing
Where are the more common metastasis sites for TNBC
Visceral sites and brain (rather than bone with luminal)
What is the typical recurrence pattern for TNBC
Recurrence by 8 years. From 10 years recurrence is very rare
What layer does a breast in situ carcinoma need to breach to become an invasive carcinoma
The basement membrane
What are the microscopic features of comedo DCIS
Polymorphism of cells, high grade
Central necrosis
What is the process that results in Paget’s disease of the breast. What is the relevance of the presence of a mass?
Malignant cells travel through ducts of breast and break through the lactiferous sinuses onto the skin of the nipple. Cause pruritis and eczema like chance ( unilateral)
If mass palpable then it is likely there is an underlying invasive breast cancer (commonly HER2+)
If no mass palpable then more likely that the underlying pathology is DCIS
What are the pathological features that distinguish LCIS from DCIS
Both form in ducts and lobules (ie the naming of them is historic and now misleading)
LCIS has the microscopic appearance of discohesive cells ( not penetrating basement membrane)
Usually have dysfunction of e-cadherin
Cells are rounded due to loss of adhesion to other cells
LCIC is not associated with Paget’s disease of the breast ie, nipple skin involvement (but does have a Pagetoid appearance within the ducts ie, discohesive cells)
LCIS is not associated with calcification
What is the natural history of LCIS, including following surgical resection
1% per year risk of invasive cancer
Ipsilateral breast only slightly more likely to be site of invasive disease
Most invasive cancers are morphologies other than lobular. 3x rate of lobular compared to general population.
It is unclear if resection of LCIS lesion lowers risk of invasive cancer
Most are ER/PR positive, so Tamoxifen is a treatment option
What are the 5 most common subtypes of DCIS, and which have worst prognosis
Cribriform
Papillary
Micropapillary
Solid (poor)
Comedo (poor)
What mutation do Lobular breast carcinomas often have
CDH1 (e-cadherin)
What are common metastatic sites for lobular carcinoma
Peritoneum, retroperitoneum, leptomeninges, GI tract, ovaries, uterus
What localised reaction do lobular carcinomas often lack, making their detection more difficult
Desmoplastic reaction